Guggenheim Capital LLC Emergent Bio Solutions Inc. Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.21 $34,816 - $62,575	-4,737 Reduced 26.34%	13,247 $97,000
Q1 2023 May 10, 2023	SELL	$7.79 - $16.29 $337,673 - $706,122	-43,347 Reduced 70.68%	17,984 $186,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $239,635 - $467,288	21,785 Added 55.09%	61,331 $724,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $33,610 - $59,893	-1,673 Reduced 4.06%	39,546 $830,000
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $1.22 Million - $1.94 Million	-44,573 Reduced 51.95%	41,219 $1.28 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $24,806 - $35,509	680 Added 0.8%	85,792 $3.52 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $1.97 Million - $3.28 Million	-59,629 Reduced 41.2%	85,112 $3.7 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $360,554 - $475,626	-7,201 Reduced 4.74%	144,741 $7.25 Million
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $221,401 - $314,679	3,911 Added 2.64%	151,942 $9.57 Million
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $124,688 - $181,024	1,446 Added 0.99%	148,031 $13.8 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $3.54 Million - $4.98 Million	44,673 Added 43.83%	146,585 $13.1 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $2.19 Million - $3.61 Million	-26,744 Reduced 20.79%	101,912 $10.5 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $15,701 - $25,871	-289 Reduced 0.22%	128,656 $10.2 Million
Q1 2020 Jun 02, 2020	SELL	$49.34 - $68.76 $12,335 - $17,190	-250 Reduced 0.19%	128,945 $7.46 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $131,404 - $151,547	2,566 Added 2.03%	129,195 $6.97 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $268,975 - $378,950	6,625 Added 5.52%	126,629 $6.62 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $320,837 - $432,872	8,037 Added 7.18%	120,004 $5.8 Million
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $575,142 - $788,958	-11,925 Reduced 9.63%	111,967 $5.66 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $722,021 - $950,581	-12,979 Reduced 9.48%	123,892 $7.34 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $4.4 Million - $5.63 Million	-84,583 Reduced 38.19%	136,871 $9.01 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $2.46 Million - $2.83 Million	-50,829 Reduced 18.67%	221,454 $11.2 Million
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $2.96 Million - $3.62 Million	-66,635 Reduced 19.66%	272,283 $14.3 Million
Q4 2017 Feb 14, 2018	SELL	$37.77 - $47.75 $957,809 - $1.21 Million	-25,359 Reduced 6.96%	338,918 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $12.4 Million - $14.7 Million	364,277	364,277 $14.7 Million

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account